Advertisement
Screener

CELYAD ONCOLOGY SA Patents: Applications Rejected

CELYAD ONCOLOGY SA Patent Applications Rejected

3 applications abandoned without a patent; the status gives the reason, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.

  • 2021-11-02: Application 17608335; Invention CELLS WITH MULTIPLEXED INHIBITORY RNA; Applicant CELYAD S.A.; Status Abandoned -- Failure to Respond to an Office Action.
  • 2021-10-28: Application 17607192; Invention CAR T-CELLS TARGETING BCMA AND USES THEREOF; Applicant CELYAD S.A.; Status Abandoned -- Failure to Respond to an Office Action.
  • 2015-06-19: Application 14654211; Invention BIOMARKER METHODS AND COMPOSITIONS; Applicant CELYAD S.A.; Status Abandoned -- Failure to Respond to an Office Action.
FiledApplicationInventionApplicantStatusPublished asInventor nameInventor countryExaminer
2021-11-0217608335CELLS WITH MULTIPLEXED INHIBITORY RNACELYAD S.A.Abandoned -- Failure to Respond to an Office ActionUS20220202863A1
Simon BORNSCHEIN
Peggy SOTIROPOULOU
Eytan BREMAN
Mikhail STEKLOV
Belgium
Belgium
Belgium
Belgium
BATES, KEENAN ALEXANDER
2021-10-2817607192CAR T-CELLS TARGETING BCMA AND USES THEREOFCELYAD S.A.Abandoned -- Failure to Respond to an Office ActionUS20220218749A1
Simon BORNSCHEIN
Jennifer BOLSÉE
Peggy SOTIROPOULOU
Belgium
Belgium
WU, JULIE ZHEN QIN
2015-06-1914654211BIOMARKER METHODS AND COMPOSITIONSCELYAD S.A.Abandoned -- Failure to Respond to an Office ActionUS20150337031A1
Sebastien MAUEN
Peter DE WAELE
Roldand GORDON-BERESFORD
Belgium
Belgium
Belgium
HAMA, JOANNE